NCT00239291View on ClinicalTrials.gov

Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

May 31, 2006

Conditions

Non-Metastatic Prostate Cancer

Interventions

DRUG

Gefitinib, radiotherapy

Trial Locations (1)

Unknown

Research site, Helsinki

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY